KZJ-10265-35946 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-03
Dose 1 — Moderna
2021-01-07
Registered in v-safe
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-01
Dose 2 — Moderna
2021-02-01
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-03
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-02-08
Health check-in — day 7, dose 2
Feeling: Good · Joint pains, Fatigue or tiredness, Nausea

Adult check-in
2021-02-18
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-03-01
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-08
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-15
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-05
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-02
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-19
Dose 3 — Moderna
2022-02-01
Health check-in — day 7, dose 3
Feeling: Poor · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-02-01
Survey response — 12 months, dose 2
MedDRA: Headache, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Hives over entire body, headaches

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-01
Report sent to call center — day 7, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-02
Survey response — day 14, dose 3
MedDRA: Urticaria — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Full body hives for 4 days

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — day 14, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-04
Call successful
Participant prefers to complete VAERS report online
2022-02-09
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-03-04
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-04-21
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-07-23
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-01-19
Survey response — 12 months, dose 3
MedDRA: Abortion spontaneous, Office visit — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Hospitalization

MedDRA releases: 2024-11
2023-01-19
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
2023-01-20
Call successful
Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-03	Moderna
2	2021-02-01	Moderna
3	2022-01-19	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-01	Successful	Participant prefers to complete VAERS report online
2022-02-01	Successful	Participant prefers to complete VAERS report online
2022-02-02	Successful 2022-02-04	Participant prefers to complete VAERS report online
2023-01-19	Successful 2023-01-20	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Swollen lymph nodes

Release 11 — 12 months, dose 2

2022-02-01

Symptoms: Hives over entire body, headaches

Release 11 — day 14, dose 3

2022-02-02

Symptoms: Full body hives for 4 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Abortion spontaneous	·	·	✓
SD	Headache	·	·	✓
SD	Urticaria	·	·	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release